CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine ; volume:25 ; number:1 ; day:18 ; month:12 ; year:2024 ; pages:1-11 ; date:12.2024
The journal of headache and pain ; 25, Heft 1 (18.12.2024), 1-11, 12.2024
- Creator
-
Baggio, Darciane F.
Gambeta, Eder
Souza, Ivana A.
Huang, Sun
Zamponi, Gerald W.
Chichorro, Juliana G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-024-01921-0
- URN
-
urn:nbn:de:101:1-2503010636486.364688441180
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Baggio, Darciane F.
- Gambeta, Eder
- Souza, Ivana A.
- Huang, Sun
- Zamponi, Gerald W.
- Chichorro, Juliana G.
- SpringerLink (Online service)
Other Objects (12)
CGRP and migraine: neurogenic inflammation revisited
Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine
Prevalence and characteristics of cutaneous allodynia in probable migraine
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
TRPM8 genetic variant is associated with chronic migraine and allodynia
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
CGRP and migraine: neurogenic inflammation revisited
Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine
Prevalence and characteristics of cutaneous allodynia in probable migraine
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
TRPM8 genetic variant is associated with chronic migraine and allodynia
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
CGRP and migraine: neurogenic inflammation revisited
Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine
Prevalence and characteristics of cutaneous allodynia in probable migraine
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
CGRP-targeted medication in chronic migraine - systematic review
TRPM8 genetic variant is associated with chronic migraine and allodynia
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Serum CGRP in migraine patients using erenumab as preventive treatment